With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial
Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine. Source: BioSpace
Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine. Source: BioSpace
Deerfield and Johns Hopkins announce Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Source: BioSpace
The opportunity to work at the leading edge of science and technology while working on solutions to some of the world's most vexing problems is what attracts people to Verily.…
When complete, the expansion is expected to double the size of Regeneron's footprint in Greenburgh. Source: BioSpace
X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace
The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace
Ionis Pharma and Janssen have strengthened their alliance with a second deal for gastrointestinal drugs. Source: BioSpace
Teva's stock jumped as investors get more hopeful about the future. Source: BioSpace
A major manufacturer of generic drugs in India failed to follow up as required on laboratory tests that showed its products at two facilities did not meet specifications, in some…
The FDA could further improve the transparency of its benefit-risk assessments in drug regulatory decisions by disclosing more information in complete response letters, BIO suggested in written comments to the…